1 Conjunctivitis Therapeutics Market Overview 1.1 Product Overview and Scope of Conjunctivitis Therapeutics 1.2 Conjunctivitis Therapeutics Segment by Type 1.2.1 Global Conjunctivitis Therapeutics Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Allergic conjunctivitis 1.2.3 Bacterial conjunctivitis 1.2.4 Viral conjunctivitis 1.3 Conjunctivitis Therapeutics Segment by Application 1.3.1 Global Conjunctivitis Therapeutics Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Outpatient 1.4 Global Conjunctivitis Therapeutics Market Size Estimates and Forecasts 1.4.1 Global Conjunctivitis Therapeutics Revenue 2017-2028 1.4.2 Global Conjunctivitis Therapeutics Sales 2017-2028 1.4.3 Conjunctivitis Therapeutics Market Size by Region: 2017 Versus 2021 Versus 2028 2 Conjunctivitis Therapeutics Market Competition by Manufacturers 2.1 Global Conjunctivitis Therapeutics Sales Market Share by Manufacturers (2017-2022) 2.2 Global Conjunctivitis Therapeutics Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Conjunctivitis Therapeutics Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Conjunctivitis Therapeutics Manufacturing Sites, Area Served, Product Type 2.5 Conjunctivitis Therapeutics Market Competitive Situation and Trends 2.5.1 Conjunctivitis Therapeutics Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Conjunctivitis Therapeutics Players Market Share by Revenue 2.5.3 Global Conjunctivitis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Conjunctivitis Therapeutics Retrospective Market Scenario by Region 3.1 Global Conjunctivitis Therapeutics Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Conjunctivitis Therapeutics Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Conjunctivitis Therapeutics Market Facts & Figures by Country 3.3.1 North America Conjunctivitis Therapeutics Sales by Country 3.3.2 North America Conjunctivitis Therapeutics Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Conjunctivitis Therapeutics Market Facts & Figures by Country 3.4.1 Europe Conjunctivitis Therapeutics Sales by Country 3.4.2 Europe Conjunctivitis Therapeutics Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Conjunctivitis Therapeutics Market Facts & Figures by Region 3.5.1 Asia Pacific Conjunctivitis Therapeutics Sales by Region 3.5.2 Asia Pacific Conjunctivitis Therapeutics Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Conjunctivitis Therapeutics Market Facts & Figures by Country 3.6.1 Latin America Conjunctivitis Therapeutics Sales by Country 3.6.2 Latin America Conjunctivitis Therapeutics Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Conjunctivitis Therapeutics Market Facts & Figures by Country 3.7.1 Middle East and Africa Conjunctivitis Therapeutics Sales by Country 3.7.2 Middle East and Africa Conjunctivitis Therapeutics Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Conjunctivitis Therapeutics Historic Market Analysis by Type 4.1 Global Conjunctivitis Therapeutics Sales Market Share by Type (2017-2022) 4.2 Global Conjunctivitis Therapeutics Revenue Market Share by Type (2017-2022) 4.3 Global Conjunctivitis Therapeutics Price by Type (2017-2022) 5 Global Conjunctivitis Therapeutics Historic Market Analysis by Application 5.1 Global Conjunctivitis Therapeutics Sales Market Share by Application (2017-2022) 5.2 Global Conjunctivitis Therapeutics Revenue Market Share by Application (2017-2022) 5.3 Global Conjunctivitis Therapeutics Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Akorn, Incorporated 6.1.1 Akorn, Incorporated Corporation Information 6.1.2 Akorn, Incorporated Description and Business Overview 6.1.3 Akorn, Incorporated Conjunctivitis Therapeutics Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Akorn, Incorporated Conjunctivitis Therapeutics Product Portfolio 6.1.5 Akorn, Incorporated Recent Developments/Updates 6.2 ALLERGAN 6.2.1 ALLERGAN Corporation Information 6.2.2 ALLERGAN Description and Business Overview 6.2.3 ALLERGAN Conjunctivitis Therapeutics Sales, Revenue and Gross Margin (2017-2022) 6.2.4 ALLERGAN Conjunctivitis Therapeutics Product Portfolio 6.2.5 ALLERGAN Recent Developments/Updates 6.3 Bausch Health 6.3.1 Bausch Health Corporation Information 6.3.2 Bausch Health Description and Business Overview 6.3.3 Bausch Health Conjunctivitis Therapeutics Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Bausch Health Conjunctivitis Therapeutics Product Portfolio 6.3.5 Bausch Health Recent Developments/Updates 6.4 Novartis AG 6.4.1 Novartis AG Corporation Information 6.4.2 Novartis AG Description and Business Overview 6.4.3 Novartis AG Conjunctivitis Therapeutics Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Novartis AG Conjunctivitis Therapeutics Product Portfolio 6.4.5 Novartis AG Recent Developments/Updates 6.5 Santen Pharmaceutical 6.5.1 Santen Pharmaceutical Corporation Information 6.5.2 Santen Pharmaceutical Description and Business Overview 6.5.3 Santen Pharmaceutical Conjunctivitis Therapeutics Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Santen Pharmaceutical Conjunctivitis Therapeutics Product Portfolio 6.5.5 Santen Pharmaceutical Recent Developments/Updates 7 Conjunctivitis Therapeutics Manufacturing Cost Analysis 7.1 Conjunctivitis Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Conjunctivitis Therapeutics 7.4 Conjunctivitis Therapeutics Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Conjunctivitis Therapeutics Distributors List 8.3 Conjunctivitis Therapeutics Customers 9 Conjunctivitis Therapeutics Market Dynamics 9.1 Conjunctivitis Therapeutics Industry Trends 9.2 Conjunctivitis Therapeutics Market Drivers 9.3 Conjunctivitis Therapeutics Market Challenges 9.4 Conjunctivitis Therapeutics Market Restraints 10 Global Market Forecast 10.1 Conjunctivitis Therapeutics Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Conjunctivitis Therapeutics by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Conjunctivitis Therapeutics by Type (2023-2028) 10.2 Conjunctivitis Therapeutics Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Conjunctivitis Therapeutics by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Conjunctivitis Therapeutics by Application (2023-2028) 10.3 Conjunctivitis Therapeutics Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Conjunctivitis Therapeutics by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Conjunctivitis Therapeutics by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Conjunctivitis Therapeutics Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Conjunctivitis Therapeutics Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Conjunctivitis Therapeutics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Conjunctivitis Therapeutics Market Competitive Situation by Manufacturers in 2021 Table 5. Global Conjunctivitis Therapeutics Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Conjunctivitis Therapeutics Sales Market Share by Manufacturers (2017-2022) Table 7. Global Conjunctivitis Therapeutics Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Conjunctivitis Therapeutics Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Conjunctivitis Therapeutics Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Conjunctivitis Therapeutics Manufacturing Sites and Area Served Table 11. Manufacturers Conjunctivitis Therapeutics Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Conjunctivitis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjunctivitis Therapeutics as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Conjunctivitis Therapeutics Sales by Region (2017-2022) & (K Units) Table 16. Global Conjunctivitis Therapeutics Sales Market Share by Region (2017-2022) Table 17. Global Conjunctivitis Therapeutics Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Conjunctivitis Therapeutics Revenue Market Share by Region (2017-2022) Table 19. North America Conjunctivitis Therapeutics Sales by Country (2017-2022) & (K Units) Table 20. North America Conjunctivitis Therapeutics Sales Market Share by Country (2017-2022) Table 21. North America Conjunctivitis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Conjunctivitis Therapeutics Revenue Market Share by Country (2017-2022) Table 23. Europe Conjunctivitis Therapeutics Sales by Country (2017-2022) & (K Units) Table 24. Europe Conjunctivitis Therapeutics Sales Market Share by Country (2017-2022) Table 25. Europe Conjunctivitis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Conjunctivitis Therapeutics Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Conjunctivitis Therapeutics Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Conjunctivitis Therapeutics Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Conjunctivitis Therapeutics Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Conjunctivitis Therapeutics Revenue Market Share by Region (2017-2022) Table 31. Latin America Conjunctivitis Therapeutics Sales by Country (2017-2022) & (K Units) Table 32. Latin America Conjunctivitis Therapeutics Sales Market Share by Country (2017-2022) Table 33. Latin America Conjunctivitis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Conjunctivitis Therapeutics Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Conjunctivitis Therapeutics Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Conjunctivitis Therapeutics Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Conjunctivitis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Conjunctivitis Therapeutics Revenue Market Share by Country (2017-2022) Table 39. Global Conjunctivitis Therapeutics Sales by Type (2017-2022) & (K Units) Table 40. Global Conjunctivitis Therapeutics Sales Market Share by Type (2017-2022) Table 41. Global Conjunctivitis Therapeutics Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Conjunctivitis Therapeutics Revenue Share by Type (2017-2022) Table 43. Global Conjunctivitis Therapeutics Price by Type (2017-2022) & (USD/Unit) Table 44. Global Conjunctivitis Therapeutics Sales (K Units) by Application (2017-2022) Table 45. Global Conjunctivitis Therapeutics Sales Market Share by Application (2017-2022) Table 46. Global Conjunctivitis Therapeutics Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Conjunctivitis Therapeutics Revenue Share by Application (2017-2022) Table 48. Global Conjunctivitis Therapeutics Price by Application (2017-2022) & (USD/Unit) Table 49. Akorn, Incorporated Corporation Information Table 50. Akorn, Incorporated Description and Business Overview Table 51. Akorn, Incorporated Conjunctivitis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Akorn, Incorporated Conjunctivitis Therapeutics Product Table 53. Akorn, Incorporated Recent Developments/Updates Table 54. ALLERGAN Corporation Information Table 55. ALLERGAN Description and Business Overview Table 56. ALLERGAN Conjunctivitis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. ALLERGAN Conjunctivitis Therapeutics Product Table 58. ALLERGAN Recent Developments/Updates Table 59. Bausch Health Corporation Information Table 60. Bausch Health Description and Business Overview Table 61. Bausch Health Conjunctivitis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Bausch Health Conjunctivitis Therapeutics Product Table 63. Bausch Health Recent Developments/Updates Table 64. Novartis AG Corporation Information Table 65. Novartis AG Description and Business Overview Table 66. Novartis AG Conjunctivitis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Novartis AG Conjunctivitis Therapeutics Product Table 68. Novartis AG Recent Developments/Updates Table 69. Santen Pharmaceutical Corporation Information Table 70. Santen Pharmaceutical Description and Business Overview Table 71. Santen Pharmaceutical Conjunctivitis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Santen Pharmaceutical Conjunctivitis Therapeutics Product Table 73. Santen Pharmaceutical Recent Developments/Updates Table 74. Production Base and Market Concentration Rate of Raw Material Table 75. Key Suppliers of Raw Materials Table 76. Conjunctivitis Therapeutics Distributors List Table 77. Conjunctivitis Therapeutics Customers List Table 78. Conjunctivitis Therapeutics Market Trends Table 79. Conjunctivitis Therapeutics Market Drivers Table 80. Conjunctivitis Therapeutics Market Challenges Table 81. Conjunctivitis Therapeutics Market Restraints Table 82. Global Conjunctivitis Therapeutics Sales Forecast by Type (2023-2028) & (K Units) Table 83. Global Conjunctivitis Therapeutics Sales Market Share Forecast by Type (2023-2028) Table 84. Global Conjunctivitis Therapeutics Revenue Forecast by Type (2023-2028) & (US$ Million) Table 85. Global Conjunctivitis Therapeutics Revenue Market Share Forecast by Type (2023-2028) Table 86. Global Conjunctivitis Therapeutics Sales Forecast by Application (2023-2028) & (K Units) Table 87. Global Conjunctivitis Therapeutics Sales Market Share Forecast by Application (2023-2028) Table 88. Global Conjunctivitis Therapeutics Revenue Forecast by Application (2023-2028) & (US$ Million) Table 89. Global Conjunctivitis Therapeutics Revenue Market Share Forecast by Application (2023-2028) Table 90. Global Conjunctivitis Therapeutics Sales Forecast by Region (2023-2028) & (K Units) Table 91. Global Conjunctivitis Therapeutics Sales Market Share Forecast by Region (2023-2028) Table 92. Global Conjunctivitis Therapeutics Revenue Forecast by Region (2023-2028) & (US$ Million) Table 93. Global Conjunctivitis Therapeutics Revenue Market Share Forecast by Region (2023-2028) Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Conjunctivitis Therapeutics Figure 2. Global Conjunctivitis Therapeutics Market Share by Type in 2021 & 2028 Figure 3. Allergic conjunctivitis Product Picture Figure 4. Bacterial conjunctivitis Product Picture Figure 5. Viral conjunctivitis Product Picture Figure 6. Global Conjunctivitis Therapeutics Market Share by Application in 2021 & 2028 Figure 7. Hospital Figure 8. Outpatient Figure 9. Global Conjunctivitis Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Conjunctivitis Therapeutics Market Size (2017-2028) & (US$ Million) Figure 11. Global Conjunctivitis Therapeutics Sales (2017-2028) & (K Units) Figure 12. Conjunctivitis Therapeutics Sales Share by Manufacturers in 2021 Figure 13. Global Conjunctivitis Therapeutics Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Conjunctivitis Therapeutics Players: Market Share by Revenue in 2021 Figure 15. Conjunctivitis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Conjunctivitis Therapeutics Sales Market Share by Region (2017-2022) Figure 17. Global Conjunctivitis Therapeutics Sales Market Share by Region in 2021 Figure 18. Global Conjunctivitis Therapeutics Revenue Market Share by Region (2017-2022) Figure 19. Global Conjunctivitis Therapeutics Revenue Market Share by Region in 2021 Figure 20. U.S. Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Taiwan Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Philippines Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Vietnam Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Mexico Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Brazil Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Argentina Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Turkey Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Saudi Arabia Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. U.A.E Conjunctivitis Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Sales Market Share of Conjunctivitis Therapeutics by Type (2017-2022) Figure 45. Manufacturing Cost Structure of Conjunctivitis Therapeutics Figure 46. Manufacturing Process Analysis of Conjunctivitis Therapeutics Figure 47. Conjunctivitis Therapeutics Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Akorn, Incorporated ALLERGAN Bausch Health Novartis AG Santen Pharmaceutical